| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.64 | 0.0002 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.58 | 0.0006 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.53 | 0.003 |